From: One-year patency control and risk analysis of eSVS®-mesh-supported coronary saphenous vein grafts
Patients (n) exclusive 3 non-device related deaths | 19 | |
---|---|---|
Gender (n; male) | 16 | |
Age (years; mean ± std; min.-max.) | 70.4 ± 9.5 (51–81) | |
Body weight (kg; mean ± std) | 80.1 ± 15.0 | |
Bodymassindex (kg/m2; mean ± std) | 28.2 ± 5.3 | |
NYHA / CCS classification (n; %) | NYHA | CCS |
I | 13 (68.4 %) | 2 (10.5 %) |
II | 4 (21.1 %) | 10 (52.7 %) |
III | 2 (10.5 %) | 5 (26.3 %) |
IV | 0 | 2 (10.5 %) |
Left ventricular ejection fraction (%; mean ± std) | 49 ± 11 | |
CAD in 1° relative (n; %) | 17 (89.5 %) | |
Arterial hypertension (n; %) | 18 (94.7 %) | |
Diabetes (n; %; on insuline/oral antidiabetics/diet) | 0 (0 %) / 2 (10.5 %)/6 (31.5 %) | |
Dyslipidemia (n; %) | 16 (84.2 %) + 1 (5.3 %) unknown | |
Smoking (n; %; current/former/never) | 2 (10.5 %)/13 (68.4 %)/4 (21.1 %) | |
Previous myocardial infarction (n; %) | 13 (68.4 %) + 5 (26.3 %) no + 1 (5.3 %) unknown | |
Previous cerebrovascular event (n; %) | 2 (10.5 %) (TIA only) | |
Previous CABG (n; %) | 0 (0 %) | |
Revascularisation (n;%; OPCAB/ECC/MECC) | 11 (57.9 %)/5 (26.3 %)/3 (15.8 %) | |
Extracorporeal circulation time (min; mean ± std)1) | 113.9 ± 35.5 (n = 8) | |
Cross clamp time (min; mean ± std)1) | 79.9 ± 25.3 (n = 8) | |
Days on intensive care unit (mean ± std) | 2.3 ± 1.3 | |
In-hospital days (mean ± std) | 10.3 ± 4.7 | |
Directly device-related complications (n) | 0 | |
MACCE (n; %) | 1 (5.3 %) (Stroke with paraparesis, complete remission) |